Container Corporation of India

Similar documents
MRF. Result Update. Accumulate

Transport Corporation of India

CONCOR. Management Meeting Update. Buy

Skipper. Result Update. Reduce

Techno Electric & Engineering

Bharat Petroleum Corporation

Berger Paints. Result Update. Downgrade to Reduce (Prev. - Accumulate) Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 06, 2017

Music Broadcast. Result Update. Buy. Valuation (x) Estimates (` Mn) Q1FY18 Result (` Mn)

Voltas. Result Update. Buy. Q4FY18 Result (` Mn) May 21, 2018

Larsen & Toubro. Result Update. Accumulate. Valuation (x) Estimates (` Bn) Q1FY18 Result (` Mn) July 26, 2018

MRF. Result Update. Accumulate

HCC. Result Update. Accumulate. Debt reduction factored in. Valuation (x) Estimates (` mn) Q2FY18 Result (` Mn) November 03, 2017

Maruti Suzuki India. Result Update. Accumulate. Growth Story Continues. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Gujarat State Petronet

NCC. Result Update. Accumulate

Result Update. Atul Auto. Accumulate

Maruti Suzuki India. Result Update. Accumulate. Product mix driving margins

Simplex Infrastructures

Result Update. Ahluwalia Contracts. Buy

Result Update. Sterling Tools. Buy

Shemaroo Entertainment

INOX Leisure. Result Update. Accumulate. Valuation (x) Estimates (` Mn) Q4FY18 Result (` Mn) May 08, 2018

Skipper. Accumulate. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

GSK Pharma. Result Update. Buy

Transport Corporation of India

Skipper. Buy. Result Update. India (Capital Goods) Institutional Research DOLAT CAPITAL

Result Update. Havells. Buy

Result Update. Sterling Tools. Accumulate

Result Update. Skipper. Sell

Balkrishna Industries

Dilip Buildcon. Result Update. Buy. Stellar performance continues

Page Industries. Annual Report Analysis. Accumulate. FINANCIALS (` Mn) July 14, 2017

Result Update. Tech Mahindra. Buy

Result Update. Khadim India. Buy

Music Broadcast. Annual Report Analysis. Buy. Financials (` mn) August 31, 2018

Kajaria Ceramics. Result Update. Buy

Infosys. Result Update. Buy

Kalpataru Power Transmission

Dixon Technologies. Annual Report Analysis. Accumulate. Annual Report The IPO year. FINANCIALS (` Mn)

Particulars Q3FY15 Q3FY14 YoY (%) Q2FY15 QoQ (%) 9MFY15 9MFY14 YoY (%) Net Sales 3,774 3, , ,453 8,

Mahanagar Gas. Result Update. Accumulate

ICICI Bank. Result Update. Buy. Mixed bag. Valuation (x) Estimates (` mn) Q3FY18 Result (` Mn)

Result Update. KEI Industries. Buy

Result Update ITC. Accumulate

Result Update. NIIT Technologies. Buy

Q3FY19 Quarterly Preview IT Services

Result Update. HDFC Bank. Accumulate

ICICI Bank. Result Update. Buy

Dilip Buildcon. Visit Note. Buy. FY18E a bumper year! Show continues!

Sagar Cement. Result Update. Buy. Valuation (x) Estimates (` mn) Q1FY19 Result (` Mn)

KEC International. Annual Report Analysis. Accumulate

JK Cement. Result Update. Buy. Q3FY18 Result (` Mn)

Q3FY13 Q3FY12 YOY(%) Q2FY13

Result Update. Yes Bank. Buy

Repco Home Finance REPCO IN

Sanofi India. Company Update. Buy

South Indian Bank. Result Update. Buy

Allcargo Logistics. Source: Company Data; PL Research

Marico Kaya BUY RESULTS REVIEW 4QFY15 29 APR 2015

Cummins India Ltd Bloomberg Code: KKC IN

Visaka Industries Ltd

BHEL SELL RESULTS REVIEW 1QFY15 13 AUG CMP (as on 12 Aug 2014) Rs 224 Target Price Rs 188

Asian Paints. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Near-term pressure, but long-term outlook positive

Fineotex Chemical Ltd

Still on track. Exhibit 1: ICT is on track for FY09E

JK Lakshmi Cement. Source: Company Data; PL Research

Ahluwalia Contracts (India)

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Transport Corporation of India Ltd.

Transport Corporation of India Ltd.

Britannia Industries

TVS Motors. Source: Company Data; PL Research

Bayer Cropscience (BYRCS IN)

SQS India BFSI Ltd HOLD. Impact of Macro Headwinds Still Hurting; Revenue from US May Pick up in FY18E

HOLD. Deleveraging story playing out RAMCO CEMENTS. Target Price: Rs 503. Q4 performance

BUY. White cement steals the show JK CEMENT. Target Price: Rs 1,220. Other highlights

Mahindra & Mahindra. Source: Company Data; PL Research

BUY. Efforts on cost cutting paying off RAMCO CEMENTS. Target Price: Rs 435. Key highlights. Key drivers FY15 FY16E FY17E

Transport Corporation of India Ltd.

Reliance Industries. Timing is everything BUY COMPANY UPDATE 1 OCT 2014

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Bharat Petroleum Corporation

Maruti Suzuki. Source: Company Data; PL Research

BUY. At inflection point NTPC. Target Price: Rs 197. Key highlights. Financial summary (Standalone) Y/E March FY16 FY17 FY18E FY19E.

LIC Housing Finance. Source: Company Data; PL Research

Garware Wall Ropes ACCUMULATE. Performance Highlights CMP. `550 Target Price `618. 2QFY2017 Result Update Textile. Investment Period 12 months

ITC. Annual Report Analysis. Accumulate. Growing amidst challenges

Cummins India. Source: Company Data; PL Research

Bloomberg Code: ATA IN

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Simplex Infrastructures

Prabhat Dairy Ltd. RESULT UPDATE 8th June, 2018

MCX Ltd. Rating: Target price: EPS: Tepid volume growth continues. Target. Rating CMP. Rs. 1,080 SELL. Rs. 1,176

Suzlon Energy Ltd RESULT UPDATE 16th August, 2017

Century Plyboards (I) Limited

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

ITC Ltd. RESULT UPDATE 27th October, 2017

Exide Industries BUY. Auto Components February 03, Volume Recovery & Cost Saving to Cushion Margins RESULT UPDATE

Transcription:

Oct16 Nov16 Dec16 Jan17 Feb17 Mar17 Apr17 May17 Jun17 Jul17 Aug17 Sep17 Company Update Container Corporation of India Buy Stacked for success CONCOR has all its key triggers in place. DFC continues to be the most important longterm trigger as apart from boosting volumes, it will aid margins. With its planned ICD expansion and focus on addressing last mile connectivity issues, it is primed to become a 3PL player in the medium term. It continues to remain our pick in the logistics space and we reiterate our BUY with an enhanced TP of ` 1690. DFC remains the key longterm growth driver The Dedicated Freight Corridor (DFC), expected in 2020 is the most important long term trigger for CONCOR. The operationalization of DFC will improve its operations as it will help cut lead times. Double stacking, the benefits of which are already visible, will further aid margins. DFC, where the USP would be reduction of haulage costs by 5 as compared to the current rail network, is also likely to price itself competitively against road. The share of rail is expected to go up from current 2 to ~354 on DFC is in place. We believe the biggest incremental market share is likely to go to CONCOR given its scale and presence across multiple locations. Building blocks for 3PL in place. CONCOR plans a capex of ` 60bn over the next five years as it takes its CFS/ICDs to 100 from the current 74. The company has commenced 5 out of the 15 planned modal logistics parks (MMLPs) in and targets to add locations by end of FY18. It is also taking adequate measures to address issues of first and last mile connectivity. This will enable it to provide third party logistics (3PL) and warehousing services, which it plans to build a hybrid model by end of FY18. This segment will help to add another revenue stream apart from its current EXIM/domestic business providing ICD, warehousing, commodity and automotive handling services at its terminals. All triggers in place; Reiterate BUY We retain our Buy rating valuing the company using DCF methodology with a price target of ` 1,690 (WACC:9%; TGR:4%). Completion of dedicated freight corridor (DFC) in 2HFY19 will be the most important trigger for CONCOR. The nearterm concerns of shift in traffic to surface transport post implementation of GST has not played out as shown by rail freight data in Q1FY18 and July (up 8.2% YoY, at 4.2mn tonnes) and August (up 25% YoY, at 4.7mn tonnes) has increased. FINANCIALS (` mn) Particulars Net Sales 59,217 56,061 63,484 71,920 % Growth (0.4) (5.3) 13.2 13.3 EBITDA 13,384 12,468 13,966 15,822 OPM (%) 22.6 22.2 22.0 22.0 Net Profit 9,508 8,580 10,026 11,425 % Growth (32.4) (9.8) 16.9 13.9 EPS (`) 39.0 35.2 41.1 46.9 % Growth (45.9) (9.8) 16.9 13.9 PER (x) 36.0 39.9 34.2 30.0 ROANW (%) 11.9 10.0 11.0 11.7 ROACE (%) 15.8 13.3 14.4 15.4 September 12, 2017 CMP ` 1,404 Target / Upside `1,690/2 BSE Sensex 31.882 NSE Nifty 10,057 Scrip Details Equity / FV Market Cap 52week High/Low `2,437mn/10/ ` 342bn USD 5.3bn `1,410/844 Avg. Volume (no) 2,382,831 NSE Symbol Bloomberg Code CONCOR Shareholding Pattern Jun 17(%) CCRI IN Promoters 54.8 MF/Banks/FIs 14.9 FIIs 26.5 Public / Others 3.7 CONCOR Relative to Sensex 115 110 105 100 95 90 85 80 75 70 Concor BSE Sensex Sr. Analyst: Vinod Chari Tel: +9122 4096 9776 Email: vinodc@dolatcapital.com Associate: Jayakanth Kasthuri Tel: +9122 4096 9771 Email: jayakanthk@dolatcapital.com

FY03 FY04 FY03 FY04 mn TEUs mn TEUs Focus on expanding infrastructure gives a competitive edge With the largest rail network of 68 ICDs/CFS of which 12 are exportimport container depots, and 17 are exclusive domestic container depots; 39 terminals perform the combined role of domestic as well as international terminals. It has a market share of 76% in the container train operator market (CTO). The management aims to scale this reach to 100 locations by 2020. The management has guided an annual capex spend of ` 10bn for FY18. The commencement of Kathuwas terminal has been a success for the company. Kathuwas is now the largest container handling terminal for managing 25,000 TEUs per month and has a capability to handle a monthly volume of 250000300000 TEUs. Also, volumes for Vizag and Pantnagar terminals are expected to gradually improve in FY18 which would further strengthen its positioning, enabling revenue, volume CAGR of 13%, 1, respectively, in 19E. 10 8 6. EXIM Domestics Revenue Mix (%) 3.0 2.5 2.0 1.5 EXIMDomestic Revenue Trend 4 1.0 2 0.5 0.0 EXIM DOMESTIC EXIM (in Mn TEUs) DOMESTIC (in Mn TEUs) 3.5 3.0 2.5 2.0 1.5 1.0 0.5 EXIM Volumes & Realization/TEUs 22,000 19,500 17,000 14,500 12,000 9,500 7,000 4,500 2,000 (500) 0.6 0.5 0.4 0.3 0.2 0.1 Domestic Volumes & Realization/TEUs 30,000 25,000 20,000 15,000 5,000 Volumes LHS Realization (`/TEUs) RHS Volumes LHS Realization (`/TEUs) RHS Building blocks in place for 3PL With a capex of ` 60bn over the next five years as it takes its CFS/ICDs to 100 from the current 74. The company has commenced 5 out of the 15 planned modal logistics parks (MMLPs) in and targets to add locations by end of FY18. It is also taking adequate measures to address issues of first and last mile connectivity. This will enable it to provide third party logistics (3PL) and warehousing services, which it plans to build a hybrid model by end of FY18. This segment will help to add another revenue stream apart from its current EXIM/domestic business providing ICD, warehousing, commodity and automotive handling services at its terminals. Five out of 15 planned multimodal logistics parks (MMLPs) are operational. It aims to add another seven MMLPs by FY18 September 12, 2017 32

` mn ` mn ` mn 80,000 70,000 60,000 50,000 40,000 30,000 20,000 Revenue & Revenue Growth (%) YoY 3 25% 2 15% 1 5% 5% 1 20,000 15,000 5,000 EBITDA & EBITDA Margin (%) YoY 35% 3 25% 2 15% 1 5% Revenue Revenue growth (%) EBITDA EBITDA Margin (%) 16,000 14,000 12,000 8,000 6,000 4,000 2,000 Net profit & Net Profit Margin (%) YoY 35% 3 25% 2 15% 1 5% Net Profit NP Margin (%) September 12, 2017 33

Income Statement (` mn) Net Sales 59,217 56,061 63,484 71,920 Total Expenditure 45,834 43,593 49,517 56,097 Operating Expenses 41,984 39,523 45,073 51,063 Employee Expenses 1,568 1,869 1,905 2,158 Selling & Adm. Expenses 2,281 2,202 2,539 2,877 Other Income 3,175 2,892 3,492 3,956 EBIDTA (Excl. OI) 13,384 12,468 13,966 15,822 EBIDTA (Incl. OI) 16,559 15,360 17,458 19,778 Gross Profit 16,557 15,324 17,458 19,778 Depreciation 3,478 3,518 3,918 4,350 Profit Before Tax 16,557 15,324 17,458 19,778 Tax 3,571 3,226 3,514 4,004 Net Profit 9,508 8,580 10,026 11,425 Balance Sheet (` mn) Sources of Funds Equity Capital 1,950 1,950 2,437 2,437 Other Reserves 81,507 86,512 91,979 98,765 Net Worth 83,457 88,462 94,417 101,202 Secured Loans 447 250 0 0 Loan Funds 447 250 0 0 Deferred Tax Liability 3,264 2,402 2,402 2,402 Total Capital Employed 87,167 91,114 96,818 103,604 Applications of Funds Gross Block 50,977 60,193 69,714 79,331 Less: Accumulated Depreciation 26,495 26,495 30,533 34,883 Net Block 24,482 33,698 39,181 44,448 Capital Work in Progress 5,133 5,071 5,122 5,173 Investments 47,754 48,375 51,754 53,754 Current Assets, Loans & Advances Inventories 177 225 244 277 Sundry Debtors 493 425 435 493 Cash and Bank Balance 7,999 4,145 2,796 2,533 Loans and Advances 7,868 7,294 5,698 6,455 sub total 16,536 12,089 9,173 9,758 Less: Current Liabilities & Provisions Current Liabilities 6,738 8,120 8,411 9,529 sub total 6,738 8,120 8,411 9,529 Net Current Assets 9,799 3,969 761 229 Total Assets 87,167 91,114 96,818 103,604 E Estimates Cash Flow (` mn) Profit before tax 13,080 11,806 13,540 15,428 Depreciation & w.o. 3,478 3,518 3,918 4,350 Direct taxes paid (3,571) (3,226) (3,514) (4,004) Change in W.C (NonCash) 7,310 1,976 1,859 270 (A) CF from Opt. Activities 20,298 14,110 15,803 16,044 Capex (1,245) (9,155) (9,572) (9,668) Free Cash Flow to Firm 19,052 4,955 6,231 6,377 Inc./ (Dec.) in Investments (36,206) (621) (3,379) (2,000) (B) CF from Invt. Activities (37,452) (9,776) (12,951) (11,668) Inc./(Dec.) in Debt 447 (197) (250) 0 Dividend Paid (Incl. Tax) (2,965) (2,777) (4,046) (4,611) (C) CF from Financing (2,520) (3,011) (3,809) (4,611) Net Change in Cash (17,881) (3,854) (1,349) (262) Opening Cash balances 25,879 7,999 4,145 2,796 Closing Cash balances 7,999 4,145 2,796 2,533 Important Ratios (A) Measures of Performance (%) EBIDTA Margin (excl. O.I.) 22.6 22.2 22.0 22.0 EBIDTA Margin (incl. O.I.) 28.0 27.4 27.5 27.5 Gross Profit Margin 28.0 27.3 27.5 27.5 Tax/PBT 27.3 27.3 25.9 26.0 Net Profit Margin 16.1 15.3 15.8 15.9 (B) As Percentage of Net Sales Operating Expenses 70.9 70.5 71.0 71.0 Employee Expenses 2.6 3.3 3.0 3.0 Administrative Expenses 3.9 3.9 4.0 4.0 (C) Measures of Financial Status Interest Coverage (x) 0.0 0.0 0.0 0.0 Debtors Period (days) 3.0 2.8 2.5 2.5 Closing stock (days) 1.1 1.5 1.4 1.4 Invent. Turnover Ratio (x) 335 249 260 260 Fixed Assets Turnover (x) 1.2 0.9 0.9 0.9 W.C Turnover (x) 6.0 14.1 83.4 314.6 NonCash W.C (` Mn) 1,800 (176) (2,034) (2,305) (D) Measures of Investment EPS (`) (excl. EO) 39.0 35.2 41.1 46.9 EPS (`) 39.0 35.2 41.1 46.9 CEPS (`) 53.3 49.6 57.2 64.7 DPS (`) 13.0 12.2 14.2 16.2 Dividend Payout (%) 33.3 34.6 34.5 34.5 Profit Ploughback (%) 66.7 65.4 65.5 65.5 Book Value (`) 342.4 363.0 387.4 415.3 RoANW (%) 11.9 10.0 11.0 11.7 RoACE (%) 15.8 13.3 14.4 15.4 RoAIC (%) 19.9 14.3 15.0 15.8 (E) Valuation Ratios CMP (`) 1,406 1,406 1,406 1,406 P/E (x) 36.0 39.9 34.2 30.0 Market Cap. (` mn) 342,660 342,660 342,660 342,660 MCap/ Sales (x) 5.8 6.1 5.4 4.8 EV (` mn) 335,108 338,765 339,864 340,127 EV/Sales (x) 5.7 6.0 5.4 4.7 EV/EBDITA (x) 25.0 27.2 24.3 21.5 P/BV (x) 4.1 3.9 3.6 3.4 FCFE/Yield (%) 5.7 1.4 1.7 1.9 Dividend Yield (%) 0.9 0.9 1.0 1.2 E Estimates September 12, 2017 34

DART RATING MATRIX Total Return Expectation (12 Months) Buy > 2 Accumulate 10 to 2 Reduce 0 to 1 Sell < DART Team Purvag Shah Managing Director purvag@dolatcapital.com +9122 4096 9747 Amit Khurana, CFA Head of Equities amit@dolatcapital.com +9122 4096 9745 CONTACT DETAILS Equity Sales Designation Email Direct Lines Kishor Bagri, CFA VP Equity Sales kishorb@dolatcapital.com +9122 4096 9746 Kartik Sadagopan VP Equity Sales kartiks@dolatcapital.com +9122 4096 9762 Kapil Yadav VP Equity Sales kapil@dolatcapital.com +9122 4096 9735 Yomika Agarwal VP FII Sales yomika@dolatcapital.com +9122 4096 9773 Derivatives Strategist Designation Email Bhavin Mehta VP Derivatives Strategist bhavinm@dolatcapital.com +9122 4096 9705 Equity Trading Designation Email P. Sridhar VP and Head of Sales Trading sridhar@dolatcapital.com +9122 4096 9728 Chandrakant Ware AVP Equity Sales Trading chandrakant@dolatcapital.com +9122 4096 9707 Derivatives Trading Designation Email Shirish Thakkar AVP Derivatives shirisht@dolatcapital.com +9122 4096 9702 Hardik Mehta Sales Trader hardikm@dolatcapital.com +9122 4096 9748 Dolat Capital Market Pvt. Ltd. 20, Rajabahadur Mansion, 1st Floor, Ambalal Doshi Marg, Fort, Mumbai 400 001

Analyst(s) Certification The research analyst(s), with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in this research report. I. Analyst(s) and Associate (S) holding in the Stock(s): (Nil) II. Disclaimer: This research report has been prepared by Dolat Capital Market Private Limited. to provide information about the company(ies) and sector(s), if any, covered in the report and may be distributed by it and/or its affiliated company(ies) solely for the purpose of information of the select recipient of this report. This report and/or any part thereof, may not be duplicated in any form and/or reproduced or redistributed without the prior written consent of Dolat Capital Market Private Limited. This report has been prepared independent of the companies covered herein. Dolat Capital Market Private Limited. and its affiliated companies are part of a multiservice, integrated investment banking, brokerage and financing group. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have provided or may provide services in respect of managing offerings of securities, corporate finance, investment banking, mergers & acquisitions, financing or any other advisory services to the company(ies) covered herein. Dolat Capital Market Private Limited. and/or its affiliated company(ies) might have received or may receive compensation from the company(ies) mentioned in this report for rendering any of the above services. Research analysts and sales persons of Dolat Capital Market Private Limited. may provide important inputs to its affiliated company(ies) associated with it. While reasonable care has been taken in the preparation of this report, it does not purport to be a complete description of the securities, markets or developments referred to herein, and Dolat Capital Market Private Limited. does not warrant its accuracy or completeness. Dolat Capital Market Private Limited. may not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. This report is provided for information only and is not an investment advice and must not alone be taken as the basis for an investment decision. The investment discussed or views expressed herein may not be suitable for all investors. The user assumes the entire risk of any use made of this information. The information contained herein may be changed without notice and Dolat Capital Market Private Limited. reserves the right to make modifications and alterations to this statement as they may deem fit from time to time. Dolat Capital Market Private Limited. and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. This report is neither an offer nor solicitation of an offer to buy and/or sell any securities mentioned herein and/or not an official confirmation of any transaction. This report is not directed or intended for distribution to, or use by any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject Dolat Capital Market Private Limited. and/or its affiliated company(ies) to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to a certain category of investors. Persons in whose possession this report may come, are required to inform themselves of and to observe such restrictions. For U.S. Entity/ persons only: This research report is a product of Dolat Capital Market Private Limited., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated brokerdealer and therefore the analyst(s) is/are not subject to supervision by a U.S. brokerdealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Dolat Capital Market Private Limited. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person or entity. In reliance on the exemption from registration provided by Rule 15a6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Dolat Capital Market Private Limited. has entered into an agreement with a U.S. registered brokerdealer Ltd Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer/entity as informed by Dolat Capital Market Private Limited. from time to time. Dolat Capital Market Private Limited. Corporate Identity Number: U65990MH1993PTC075189 Member: BSE Limited and National Stock Exchange of India Limited. SEBI Registration No: BSE INB010710052 & INF010710052, NSE INB230710031& INF230710031, Research: INH000000685 Registered office: Office No. 141, Centre Point, Somnath, Daman 396 210, Daman & Diu Board: +9122 40969700 Fax: +9122 22651278 Email: research@dolatcapital.com www.dolatcapital.com Our Research reports are also available on Reuters, Thomson Publishers, DowJones and Bloomberg (DCML <GO>)